Anti-Human IL5 Recombinant Antibody (Reslizumab) (CAT#: TAB-136)

Recombinant monoclonal antibody to IL5. Reslizumab is a humanized monoclonal antibody intended for the treatment of eosinophil-meditated inflammations of the airways, skin and gastrointestinal tract.

Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
RNA Expression

Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Rat
  • Derivation
  • Humanized (from rat)
  • Type
  • IgG4
  • Specificity
  • Tested positive against native human antigen.
  • Species Reactivity
  • Human
  • Applications
  • Suitable for use in Neut, ELISA, IF, IP, FuncS, FC, IHC and most other immunological methods.
  • Trade name
  • cinquil
  • CAS
  • 241473-69-8
  • Generic Name
  • Reslizumab
  • Related Disease
  • Adult eosinophilic asthma

Product Property

  • Purity
  • >95.0% as determined by analysis by SDS-PAGE.
  • Storage
  • Store at -20°C for long-term storage. Store at 2-8°C for up to one month. Avoid freeze/thaw cycles.

Target

  • Alternative Names
  • Reslizumab;cinquil;241473-69-8;SCH 55700;SCH55700;CDP835;CEP-38072;hu39D10;IL5;interleukin 5 (colony-stimulating factor, eosinophil);interleukin-5;B cell differentiation factor I;EDF;eosinophil differentiation factor;IL 5;interleukin 5;T cell replacing fa

Related Resources

  • Biosimilar Overview
  • Related Diseases
Please refer to Reslizumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Reslizumab.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Reslizumab"

Afuco™ Anti-IL5 ADCC Recombinant Antibody (Reslizumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to IL5. Reslizumab is a humanized monoclonal antibody intended for the treatment of eosinophil-meditated inflammations of the airways, skin and gastrointestinal tract.

See other products for "IL5"

Select a product category from the dropdown menu below to view related products.
Please select product type
Humanized Antibody Neutralizing Antibody Blocking Antibody Recombinant Antibody Fab Fragment Antibody scFv Fragment Antibody ADCC Enhanced Antibody
CAT Product Name Application Type
TAB-031 Anti-Human IL5 Recombinant Antibody (Mepolizumab) IF, IP, Neut, FuncS, ELISA, FC, ICC IgG1 - kappa

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for TAB-136. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare